Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

jpost.com - JERUSALEM POST STAFF - How Evogene is changing the future for the pharma and agriculture markets
How Evogene is changing the future for the pharma and agriculture markets
The Jerusalem Post

In the past decade, investments in AI-driven drug discovery companies have surpassed $59.3 billion, driven by the prospect of faster development timelines and lower attrition rates across clinical programs. Most of that capital has gone toward…

marketbeat.com - Royalty Pharma PLC $RPRX Shares Sold by Inspire Investing LLC
Royalty Pharma PLC $RPRX Shares Sold by Inspire Investing LLC
MarketBeat

Inspire Investing LLC cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 82.8% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,093…

thehindubusinessline.com - Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port
Pharma exporters raise red flag over JNCH customs delays at Nhava Sheva Port
BusinessLine

Pharmaceutical exporters and importers are grappling with delays and procedural bottlenecks in customs clearances at Jawaharlal Nehru Custom House (JNCH) Nhava Sheva Port, India's largest container port in Mumbai. The Pharmaceuticals Export…

marketbeat.com - Fideuram Intesa Sanpaolo Private Banking S.P.A. Has $439,000 Stock Holdings in Royalty Pharma PLC $RPRX
Fideuram Intesa Sanpaolo Private Banking S.P.A. Has $439,000 Stock Holdings in Royalty Pharma PLC $RPRX
MarketBeat

Fideuram Intesa Sanpaolo Private Banking S.P.A. trimmed its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 92.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange…

marketbeat.com - Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Holdings in Royalty Pharma PLC $RPRX
Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Holdings in Royalty Pharma PLC $RPRX
MarketBeat

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 42.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission.

swissinfo.ch - Jessica Davis Plüss - How a Swiss lab is finding new cures in old drugs
How a Swiss lab is finding new cures in old drugs
www.swissinfo.ch

Five years ago Vladimir Katanaev's lab at the University of Geneva made a startling discovery. They found that widely available zinc salts – which were approved in the US in 1997 to treat a metabolic disorder called Wilson Disease –…

fool.com - Adria Cimino - Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)
Could Buying Eli Lilly Stock Today Set You Up for Life? (Hint: Yes.)
The Motley Fool

Over the past few years, Eli Lilly (LLY +1.35%) has been offering investors a unique combination of safety and growth. Investors generally turn to pharmaceutical stocks for their steady revenue streams -- patients need their medicines during any…

fool.com - Andy Gould - IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?
The Motley Fool

The iShares U.S. Pharmaceuticals ETF (IHE +2.72%) offers lower fees and a higher dividend yield, while the Invesco Pharmaceuticals ETF (PJP +2.84%) spreads its holdings more evenly across the sector's biggest players. Investors seeking…

zerohedge.com - Tyler Durden - Vertically Integrated Nations, Production For Security, And Rate Cuts
Vertically Integrated Nations, Production For Security, And Rate Cuts
Zero Hedge

Submitted by Peter Tchir of Academy Securities Let's start with the important stuff: Hope you are having a great 4 of July 250 Anniversary Weekend. Yields gained back some ground after the relatively weak jobs report (headline plus revisions was…

marketbeat.com - Elevation Point Wealth Partners LLC Makes New $1.33 Million Investment in Teva Pharmaceutical Industries Ltd. $TEVA
Elevation Point Wealth Partners LLC Makes New $1.33 Million Investment in Teva Pharmaceutical Industries Ltd. $TEVA
MarketBeat

Elevation Point Wealth Partners LLC purchased a new stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange…

thehindubusinessline.com - Stocks in Focus today: Supriya Lifescience; Rubicon Research; Fortis Healthcare; Fermenta Biotech
Stocks in Focus today: Supriya Lifescience; Rubicon Research; Fortis Healthcare; Fermenta Biotech
BusinessLine

Supriya Lifescience Ltd. on Saturday, July 4, said the Special Investigation and Intelligence branch of the Customs Department has initiated probe against its general manager, sales and marketing officer Sreekant Sreedharan. The company said the…

marketbeat.com - HB Wealth Management LLC Purchases 3,907 Shares of Eli Lilly and Company $LLY
HB Wealth Management LLC Purchases 3,907 Shares of Eli Lilly and Company $LLY
MarketBeat

HB Wealth Management LLC raised its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 6.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor…

thehindubusinessline.com - Biz built at quantum computing speed
Biz built at quantum computing speed
BusinessLine

Whether it's quantum computers that can accelerate drug discovery or networks designed to withstand future cyberattacks — a new generation of Indian startups are pursuing such opportunities at the cutting edge of information technology.

marketbeat.com - Simplify Asset Management Inc. Sells 11,276 Shares of Eli Lilly and Company $LLY
Simplify Asset Management Inc. Sells 11,276 Shares of Eli Lilly and Company $LLY
MarketBeat

Simplify Asset Management Inc. cut its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 40.3% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,703 shares of the company's…

marketbeat.com - TCI Wealth Advisors Inc. Sells 1,237 Shares of Eli Lilly and Company $LLY
TCI Wealth Advisors Inc. Sells 1,237 Shares of Eli Lilly and Company $LLY
MarketBeat

TCI Wealth Advisors Inc. reduced its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 15.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional…

Receive a Daily briefing on Pharma Industry News

Get Started